mRNA Manufacturing

Navigating mRNA Manufacturing with Flexibility and Innovation

Michael van der Horst, Ph.D.

mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

CDMO

Maximizing Outsourcing Benefits for Virtual Pharma Companies

William Kazimier

Tedor Pharma Services

Lipid Nanoparticles

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Antonio Costa, Ph.D.

DIANT Pharma

CDMO Partnerships

Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics

Samsung Biologics

Clinical and Commercial Manufacturing

Reach the Patient Quicker with GBI’s Manufacturing Solutions

Muctarr Sesay, Ph.D.

GBI

New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

Jessica Madigan; Normand Blais

BIOVECTRA

Expanded CDMO Capabilities

On the Journey to Support Drug Developers With End-to-End Outsourcing

Michelle Hall

Mikart

CDMO Partnerships

Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market

Daniel Buckley

Samsung Biologics

Lipid Nanoparticles

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Microbiome Therapeutic Innovation

Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future

Stacy Burns-Guydish, Ph.D.; Gary Henderson

List Labs

Viral Vector Manufacturing

Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control

Chris Berger; Kilian Witzel

Avid Bioservices

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

Eunseo (Ency) Lee, Ph.D; Jungkeun (Henry) Oh; Hanel Hwang

Samsung Biologics

Pharmaceutical Consultancy

Staying Ahead of the Curve with Outsourced Program Management

PharmaLex

Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

Rich Nelson; John Hufnagel; Rachel Castro

PCI Pharma Services

Overcoming the Challenges of an Ever-changing Biopharma Landscape

Integrity

Quality by Design

A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies

Lynda Menard, Ph.D.; Grant Henderson, Ph.D.

Vernal Biosciences

Microbiome-Based CDMO

Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing

Stacy Burns-Guydish, Ph.D.; Jonathan Yongwan Jo; Gary Henderson; Michael Kimble

List Labs

Biomanufacturing

New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!

Danielle Alvarez

Pharma's Almanac

mRNA Manufacture

Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers

Tonia Becker

Nice Insight